Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002066177 | SCV002345076 | likely benign | Acromesomelic dysplasia 1, Maroteaux type; Tall stature-scoliosis-macrodactyly of the great toes syndrome | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004702530 | SCV005204399 | uncertain significance | not specified | 2024-06-12 | criteria provided, single submitter | clinical testing | Variant summary: NPR2 c.2105T>A (p.Met702Lys) results in a non-conservative amino acid change located in the Protein kinase domain (IPR000719) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00026 in 251378 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in NPR2 causing NPR2-Related Disorders, allowing no conclusion about variant significance. To our knowledge, no occurrence of c.2105T>A in individuals affected with NPR2-Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 760980). Based on the evidence outlined above, the variant was classified as uncertain significance. |
Prevention |
RCV004533603 | SCV004720258 | likely benign | NPR2-related disorder | 2019-06-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |